Crossmark

CYP2C19 point-of-care testing: where are we now and where should we go?

Crossref DOI link: https://doi.org/10.1038/s41397-025-00375-0

Published Online: 2025-06-13

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shea, Leticia A. https://orcid.org/0000-0002-4861-2626
License Information

Text and Data Mining valid from 2025-06-13

Version of Record valid from 2025-06-13
More Information

Article History

Received: 3 December 2024

Revised: 12 May 2025

Accepted: 29 May 2025

First Online: 13 June 2025

Competing interests

: The authors declare no competing interests.